Avantax Advisory Services Inc. Invests $494,000 in Option Care Health, Inc. (NASDAQ:OPCH)

Key Points

• Avantax Advisory Services Inc. has acquired 14,133 shares of Option Care Health, Inc. (NASDAQ:OPCH), valued at approximately $494,000, as noted in their recent 13F filing with the SEC.
• Several institutional investors, including the Public Employees Retirement System of Ohio and State of Michigan Retirement System, have increased their stakes in Option Care Health, indicating a strong interest in the company.
• Analysts are optimistic about OPCH, with eight buy ratings and a consensus target price of $35.75, reflecting confidence in the company’s future performance.

Avantax Advisory Services Inc. bought a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 14,133 shares of the company's stock, valued at approximately $494,000.

Several other hedge funds have also recently bought and sold shares of the stock. Bessemer Group Inc. lifted its position in Option Care Health by 62.3% during the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock worth $54,000 after buying an additional 599 shares in the last quarter. Quadrant Capital Group LLC increased its position in shares of Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after acquiring an additional 1,099 shares during the last quarter. Public Employees Retirement System of Ohio raised its holdings in Option Care Health by 21.6% during the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after acquiring an additional 332 shares in the last quarter. Wealthquest Corp acquired a new position in Option Care Health during the first quarter valued at approximately $66,000. Finally, Farther Finance Advisors LLC boosted its position in Option Care Health by 434.8% during the first quarter. Farther Finance Advisors LLC now owns 1,920 shares of the company's stock valued at $67,000 after purchasing an additional 1,561 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Stock Performance

OPCH traded up $0.30 during trading on Friday, hitting $28.20. The stock had a trading volume of 1,072,228 shares, compared to its average volume of 1,608,567. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. The company has a 50 day moving average price of $30.64 and a 200-day moving average price of $31.92. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The firm has a market cap of $4.58 billion, a price-to-earnings ratio of 22.56, a P/E/G ratio of 1.76 and a beta of 0.79.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The business had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same period last year, the firm earned $0.30 earnings per share. Option Care Health's revenue for the quarter was up 15.4% compared to the same quarter last year. As a group, research analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on OPCH shares. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. Barrington Research restated an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a report on Thursday, July 10th. JMP Securities increased their price target on shares of Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research note on Thursday, July 31st. Finally, Citigroup reissued an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. One equities research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $35.75.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.